Manel Cascalló

Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.

Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ.

Allera Health Products, Inc. provides healthcare products. It develops supplements that enhance immune system and drugs that fight illness and diseases. Its products include ProLigna and ImmunExtra. The company was founded in 2005 and is headquartered in St. Petersburg, FL.

Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Part of ARKO Corp., GPM Empire is a company that distributes motor fuels. The company is based in Dallas, TX. The company was founded in 1998. Richard Golman has been the CEO of the company since 2019. GPM Empire was acquired by GPM Investments LLC on October 07, 2020 for $400 million.

Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX.

MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA.

Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD.

Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ.

Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland.

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.

Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million.

Part of MediGene AG, NeuroVir Therapeutic, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company is based in San Diego, CA. The company was founded by Michael R. Hayden, Frank Tufaro. NeuroVir Therapeutic was acquired by MediGene AG on January 12, 2001 for $53 million.

Wellstat Ophthalmics Corp. provides healthcare services. The private company is based in Gaithersburg, MD. The company was founded by Michael Kaleko, Sheila Connelly.

Cra Advisors LLC provides investment advisory services. The private company is based in New York. The American company was founded by Jeffrey J. Kraws. Jeffrey J. Kraws has been the CEO since incorporation.

Part of US Patent Innovations LLC, US Medical Innovations LLC is a privately held FDA registered life science, biomedical and robotic device company based in Takoma Park, MD. US Medical Innovations is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives. The company develops products for laparoscopic, robotic and cancer surgeries. The company was founded in 2009 by Jerome Canady and Kimberly Wiley, with Jerome Canady serving as CEO since then.

Protocol Intelligence, Inc. is an American company that is developing an intelligent navigational system for myeloma oncologists. The system includes software, human data curation, and decision support that advises physicians on which drugs to use and when to use them, optimized for each patient's evolving needs and physician-imposed constraints.

Part of NightHawk Biosciences, Inc., Scorpius BioManufacturing, Inc. is a contract research and manufacturing organization focused on cell- and gene-based therapies and large molecule biologics. The company is based in San Antonio, TX. The company provides clinical-scale biomanufacturing, analytical, and R&D services to pharmaceutical and biotech companies from its facilities in Texas. Scorpius plans to offer commercial-scale biomanufacturing from its newly announced site. The company was founded by Jeff A. Wolf, and Stephan Kutzer has been the CEO of the company since 2022.